The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prospective evaluation of a 12-gene assay on treatment recommendations in patients with stage II colon cancer.
Geetika Srivastava
No relevant relationships to disclose
Lindsay Anne Renfro
Research Funding - Genomic Health
Robert J. Behrens
No relevant relationships to disclose
Margarita Lopatin
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Calvin Chao
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Gamini S. Soori
No relevant relationships to disclose
Shaker R. Dakhil
No relevant relationships to disclose
Rex Bradford Mowat
No relevant relationships to disclose
J. Phillip Kuebler
No relevant relationships to disclose
George P. Kim
No relevant relationships to disclose
Miroslaw Mazurczak
No relevant relationships to disclose
Mark Lee
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Steven R. Alberts
No relevant relationships to disclose